Tempest Therapeutics, Inc.
NASDAQ:TPST
0.9411 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -29.491 | -35.709 | -28.302 | -19.208 | -44.568 | -27.192 | -84.578 | -82.26 | -73.219 | -49.52 | -29.044 | -13.51 |
| Depreciation & Amortization
| 0.381 | 0.638 | 0.374 | 0.339 | 1.052 | 0.032 | 0.028 | 2.238 | 1.286 | 0.45 | 0.231 | 0.093 |
| Deferred Income Tax
| -3.571 | 0 | 0 | 0 | -2.573 | 0 | 0 | 0 | 0 | 0 | 0 | -0.599 |
| Stock Based Compensation
| 2.546 | 1.561 | 1.105 | 0.453 | 0.31 | 1.427 | 6.893 | 9.215 | 19.337 | 12.407 | 5.094 | 1.382 |
| Change In Working Capital
| -2.677 | 0.868 | -0.613 | -1.071 | -2.053 | 1.036 | -1.844 | 4.577 | -0.532 | 12.401 | 9.424 | 0.599 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.263 | 0.001 | -0.209 | -0.574 | -0.469 | 0.32 | -1.452 | -1.178 | -0.171 | 2.317 | -0.721 | 0.599 |
| Other Working Capital
| -2.414 | 0.867 | -0.404 | -0.497 | -1.584 | 0.716 | -0.392 | 5.755 | -0.361 | 10.084 | 10.145 | -0.599 |
| Other Non Cash Items
| 5.455 | 1.57 | 1.479 | 0.47 | 6.92 | 2.221 | 67.562 | 19.365 | 24.922 | -6.326 | -3.799 | 0.879 |
| Operating Cash Flow
| -27.357 | -31.072 | -25.957 | -19.017 | -41.222 | -23.647 | -20.34 | -61.734 | -50.286 | -30.588 | -18.094 | -11.156 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -0.17 | -0.562 | -0.135 | -0.05 | -0.397 | -0.036 | -0.004 | -2.586 | -5.229 | -2.804 | -0.719 | -0.849 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | -1.332 | 0.462 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | -68.857 | -84.421 | -96.725 | -57.603 | -15.974 | -16.698 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 4.385 | 2.492 | 87.789 | 95.102 | 64.345 | 29.228 | 5.67 | 0 |
| Other Investing Activites
| 0 | 0 | 0.038 | 0.044 | 0 | 0.476 | -1.45 | -1.553 | -0.681 | -1.609 | 0.005 | -0.093 |
| Investing Cash Flow
| -0.17 | -0.562 | -0.097 | -0.006 | 3.988 | 1.124 | 0.458 | 8.095 | -38.29 | -32.788 | -11.018 | -17.64 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 0 | -4.739 | -14.905 | -0.037 | -0.202 | -6.48 | -4.465 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 35.602 | 8.861 | 33.425 | 34.599 | 27.145 | 38.756 | 0.002 | 54.148 | 125.386 | 51.733 | 32.414 | 34.992 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.036 | 7.281 | 40.543 | 34.599 | 23.003 | 33.316 | -0.129 | 0.223 | 1.323 | -0.021 | 32.414 | 4.039 |
| Financing Cash Flow
| 35.602 | 11.403 | 59.063 | 34.599 | 26.943 | 78.552 | -4.463 | 54.148 | 125.386 | 51.712 | 32.414 | 39.031 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| -0.793 | 0 | 0 | 0.221 | 0.033 | 0.118 | -0.129 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 8 | -20.231 | 33.009 | 15.576 | -9.819 | 55.708 | -26.307 | 0.706 | 37.007 | -11.664 | 3.302 | 10.235 |
| Cash At End Of Period
| 39.23 | 31.598 | 51.829 | 18.82 | 63.512 | 73.331 | 17.623 | 43.93 | 43.421 | 6.414 | 18.078 | 14.776 |